Find information on thousands of medical conditions and prescription drugs.

Tolcapone

Tolcapone, an inhibitor of catechol-O-methyltransferase (COMT), is used in the treatment of Parkinson’s disease as an adjunct to levodopa/carbidopa therapy. It is a yellow, odorless, non-hygroscopic, crystalline compound with a relative molecular mass of 273.25. The chemical name of tolcapone is 3,4-dihydroxy-4’-methyl-5-nitrobenzophenone. Its empirical formula is C14H11NO5.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]



AHRQ report on treatment of Parkinson's disease - Clinical Briefs Agency for Healthcare Research and Quality
The Agency for Healthcare Research and Quality has released a new evidence report on Parkinson's disease. "Diagnosis and Treatment of Parkinson's Disease: ...
Serious Liver Injury - drug-induced liver injury
Leading Reason For Drug Removals, Restrictions People who experience acute liver failure become critically ill in a matter of days, with most cases ...
Parkinson's disease
Parkinson's disease (PD) is a progressive movement disorder marked by tremor, rigidity, slow movements (bradykinesia), and postural instability. It occurs ...
Parkinson's disease
Parkinson's disease (PD) is a progressive movement disorder marked by tremors, rigidity, slow movements (bradykinesia), and postural instability. It occurs ...
Parkinson's Disease as Multifactorial Oxidative Neurodegeneration: Implications for Integrative Management
Abstract Parkinson's disease (PD) is the most common movement pathology, severely afflicting dopaminergic neurons within the substantia nigra (SN) ...
Parkinson's Disease: The Treatment Options. - Review - book reviews
Parkinson's Disease: The Treatment Options Wolfgang Oertel, Peter LeWitt Martin Dunitz, 65 [pounds sterling], pp 272 ISBN 1 85317 379 7 Rating: *** ...
Liver Risk Warning Added to Parkinson's Drug - drug Tasmar must have warning label - Brief Article
FDA and the maker of Tasmar (tolcapone), a drug for treating Parkinson's disease, have warned doctors about three fatal liver injuries associated with ...
Parkinson's disease - Science, Medicine, and the Future
Research is continuing on new drugs for Parkinson's disease. Parkinson's disease is caused by the death of nerve cells in an area of the brain called the ...

Home Contact Resources Exchange Links ebay